|Bid||204.16 x 800|
|Ask||204.54 x 800|
|Day's Range||202.01 - 208.13|
|52 Week Range||71.90 - 306.72|
|Beta (5Y Monthly)||0.45|
|PE Ratio (TTM)||23.90|
|Earnings Date||Feb 10, 2021 - Feb 15, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||269.00|
Quidel saw its IBD SmartSelect Composite Rating rise to 97 Tuesday, up from 94 the day before. The new rating is a sign the stock is outpacing 97% of all stocks when it comes to the most important stock-picking criteria.
Globus Medical's (GMED) recent product launches are seeing tremendous uptake.
Insulet's (PODD) Omnipod DASH system provides 72 hours of continuous insulin therapy, simplifying lives with no more daily injection.